Weige Tan

1.6k citations

24 papers · 1.2k indexed · h-index 17

Impact in

Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Molecular Biology top 10%
- Circular RNAs in diseases
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- RNA Research and Splicing
- Extracellular vesicles in disease

Papers in ⓘ

Cancer Research 16
- MicroRNA in disease regulation 10
- Cancer-related molecular mechanisms research 6
- Breast Cancer Treatment Studies 4
- Cancer Genomics and Diagnostics 3
Molecular Biology 13
- Circular RNAs in diseases 6
- Epigenetics and DNA Methylation 2

Co-authors: Chang Gong (10 shared papers)Gehao Liang (6 shared papers)Erwei Song (7 shared papers)Bodu Liu (3 shared papers)Shaohua Qu (3 shared papers)Wenjing Zhong (3 shared papers)Zihao Liu (3 shared papers)You Zhou (2 shared papers)
Journals: Oncotarget (3 papers)The Oncologist (2 papers)Journal of Cellular and Molecular Medicine (2 papers)Cell Death Discovery (1 paper)Cell Death and Disease (1 paper)
Partner nations: China United Kingdom France

In The Last Decade

Weige Tan

24 papers receiving 1.2k citations

Peers

Countries citing papers authored by Weige Tan

Since Specialization

Citations

This map shows the geographic impact of Weige Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weige Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weige Tan more than expected).

Fields of papers citing papers by Weige Tan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weige Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weige Tan. The network helps show where Weige Tan may publish in the future.

Co-authors

The 25 scholars most cited alongside Weige Tan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Weige Tan Line = papers co-authored together Weige Tan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Circular RNA hsa_circ_001783 regulates breast cancer progression via sponging miR-200c-3p Cell Death and Disease ·Zihao Liu, You Zhou, Gehao Liang, Yun Ling, Weige Tan, Luyuan Tan, Robert Andrews, Wenjing Zhong, Xuanxuan Zhang, Erwei Song, Chang Gong	2019	268
2	Autophagy-associated circRNA circCDYL augments autophagy and promotes breast cancer progression Molecular Cancer ·Gehao Liang, Yun Ling, Maryam Mehrpour, Phei Er Saw, Zihao Liu, Weige Tan, Zhenluan Tian, Wenjing Zhong, Wanyi Lin, Qing Luo, Qun Lin, Qiufang Li, You Zhou, Ahmed Hamaï, Patrice Codogno, Jun Li, Erwei Song, Chang Gong	2020	189
3	MicroRNAs and cancer: Key paradigms in molecular therapy (Review) Oncology Letters ·Weige Tan, Bodu Liu, Shaohua Qu, Gehao Liang, Wei Luo, Chang Gong	2017	162
4	BRMS1L suppresses breast cancer metastasis by inducing epigenetic silence of FZD10 Nature Communications ·Chang Gong, Shaohua Qu, Xiao-Bin Lv, Bodu Liu, Weige Tan, Yan Nie, Fengxi Su, Qiang Liu, Herui Yao, Erwei Song	2014	87
5	miR-145-5p Suppresses Breast Cancer Progression by Inhibiting SOX2 Journal of Surgical Research ·Wei Tang, Xiaoshen Zhang, Weige Tan, Jin Gao, Lingxiao Pan, Xigang Ye, Lun Chen, Wenbo Zheng	2018	69
6	Metformin mediates induction of miR‐708 to inhibit self‐renewal and chemoresistance of breast cancer stem cells through targeting CD47 Journal of Cellular and Molecular Medicine ·Weige Tan, Hailin Tang, Xinhua Jiang, Feng Ye, Lili Huang, Dingbo Shi, Laisheng Li, Xiaojia Huang, Li Li, Xiaoming Xie, Xinhua Xie	2019	54
7	circEPSTI1 regulates ovarian cancer progression via decoying miR‐942 Journal of Cellular and Molecular Medicine ·Jing Xie, Shufen Wang, Gen-lin Li, Xia Zhao, Feng Jiang, Jie Liu, Weige Tan	2019	52
8	Prognostic Value of a BCSC-associated MicroRNA Signature in Hormone Receptor-Positive HER2-Negative Breast Cancer EBioMedicine ·Chang Gong, Weige Tan, Kai Chen, Na You, Shan Zhu, Gehao Liang, Xinhua Xie, Qian Li, Yunjie Zeng, Nengtai Ouyang, Zhihua Li, Mu‐Sheng Zeng, Shi‐Mei Zhuang, Wan-Yee Lau, Qiang Liu, Dong Yin, Xueqin Wang, Fengxi Su, Erwei Song	2016	44
9	Preoperative prediction nomogram based on primary tumor miRNAs signature and clinical‐related features for axillary lymph node metastasis in early‐stage invasive breast cancer International Journal of Cancer ·Xinhua Xie, (unknown), Weige Tan, Bo Chen, Xiaojia Huang, Cheng Peng, Shumei Yan, Lu Yang, Cailu Song, Jianwei Wang, Wenbo Zheng, Hailin Tang, Xiaoming Xie	2017	40
10	Estrogen receptor beta as a prognostic factor in breast cancer patients: A systematic review and meta-analysis Oncotarget ·Weige Tan, Qian Li, Kai Chen, Fengxi Su, Erwei Song, Chang Gong	2016	34
11	Potentiated DNA Damage Response in Circulating Breast Tumor Cells Confers Resistance to Chemotherapy Journal of Biological Chemistry ·Chang Gong, Bodu Liu, Yandan Yao, Shaohua Qu, Wei Luo, Weige Tan, Qiang Liu, Herui Yao, Lee Zou, Fengxi Su, Erwei Song	2015	33
12	<p>BCL11A enhances stemness and promotes progression by activating Wnt/β-catenin signaling in breast cancer</p> Cancer Management and Research ·Lewei Zhu, Ruilin Pan, Dan Zhou, Guolin Ye, Weige Tan	2019	31
13	EIF4A3-induced circZFAND6 promotes breast cancer proliferation and metastasis through the miR-647/FASN axis Life Sciences ·Xiaojia Huang, Weige Tan, Ziteng Liu, Xiaoyan Fu, Zongyan Li, Shengqing Lai, Qian Li, Xiaofang Zhong, Fanli Qu, Huayao Zhang, Haiyan Li	2023	27
14	PIWI-interacting RNA-YBX1 inhibits proliferation and metastasis by the MAPK signaling pathway via YBX1 in triple-negative breast cancer Cell Death Discovery ·Linyu Wu, Shanshan Huang, W. H. Tian, Peng Liu, Yi Xie, Yu Qiu, Xing Li, Yuhui Tang, Shaoquan Zheng, Yuying Sun, Hailin Tang, Wei Du, Weige Tan, Xinhua Xie	2024	25
15	Diagnostic and prognostic value of serum MACC1 in breast cancer patients Oncotarget ·Weige Tan, Xinhua Xie, Laisheng Li, Hailin Tang, Xigang Ye, Lun Chen, Wei Tang, Jin Gao, Lingxiao Pan, Xiaoshen Zhang, Feng Ye, Xing Li, Lu Yang, Xiaoming Xie, Wenbo Zheng	2016	20
16	Construction of an immune-related genes nomogram for the preoperative prediction of axillary lymph node metastasis in triple-negative breast cancer Artificial Cells Nanomedicine and Biotechnology ·Weige Tan, Xinhua Xie, Zhongying Huang, Lun Chen, Wei Tang, Renjie Zhu, Xigang Ye, Xiaoshen Zhang, Lingxiao Pan, Jin Gao, Hailin Tang, Wenbo Zheng	2019	19
17	Incorporating MicroRNA into Molecular Phenotypes of Circulating Tumor Cells Enhances the Prognostic Accuracy for Patients with Metastatic Breast Cancer The Oncologist ·Weige Tan, Gehao Liang, Xinhua Xie, Wen G. Jiang, Luyuan Tan, Andrew J. Sanders, Zihao Liu, Yun Ling, Wenjing Zhong, Zhenluan Tian, Wanyi Lin, Chang Gong	2019	17
18	A combination of Nottingham prognostic index and IHC4 score predicts pathological complete response of neoadjuvant chemotherapy in estrogen receptor positive breast cancer Oncotarget ·Weige Tan, Wei Luo, Weijuan Jia, Gehao Liang, Xinhua Xie, Wenbo Zheng, Erwei Song, Fengxi Su, Chang Gong	2016	10
19	Oncologic outcomes and radiation safety of nipple-sparing mastectomy with intraoperative radiotherapy for breast cancer Breast Cancer ·Lingxiao Pan, Changsheng Ye, Lun Chen, Wei Tang, Xiaoshen Zhang, Jin Gao, Rui Wu, Xigang Ye, Weige Tan, Minghui Wan, Wenbo Zheng	2019	8
20	The role of circRNAs and miRNAs in drug resistance and targeted therapy responses in breast cancer Cancer Drug Resistance ·Meilan Zhang, Zhaokuan Zheng, Shouliang Wang, Ruihan Liu, Mengli Zhang, Zhiyun Guo, Hao Wang, Weige Tan	2024	5

About Weige Tan

Weige Tan is a scholar working on Cancer Research, Molecular Biology, Oncology, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 24 papers that have together received 1.2k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (10 papers), Cancer Cells and Metastasis (8 papers), Cancer-related molecular mechanisms research (6 papers), Circular RNAs in diseases (6 papers), Breast Cancer Treatment Studies (4 papers), HER2/EGFR in Cancer Research (3 papers), Cancer Genomics and Diagnostics (3 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Cancer Research (849 citations), Molecular Biology (951 citations), Oncology (198 citations), Pathology and Forensic Medicine (58 citations) and Immunology (63 citations). Weige Tan has collaborated with scholars based in China, United Kingdom and France. Frequent co-authors include Chang Gong, Gehao Liang, Erwei Song, Bodu Liu, Shaohua Qu, Wenjing Zhong, Zihao Liu, You Zhou, Yun Ling and Wei Luo. Their work appears in journals such as Oncotarget, The Oncologist, Journal of Cellular and Molecular Medicine, Cell Death Discovery and Cell Death and Disease.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact